Cencora Inc stock reaches all-time high at 309.38 USD

Cencora Inc stock has reached a new all-time high, hitting 309.38 USD, marking a significant milestone for the company. With a substantial market capitalization of $59.8 billion and a "GOOD" financial health rating according to InvestingPro, the company continues to demonstrate strong market presence. Over the past year, Cencora Inc has experienced a robust growth trajectory, with its stock price increasing by 38.26%. The stock’s impressive year-to-date return of 35.41% and analyst consensus pointing to further upside potential underscore investor confidence and the company’s strong market position. InvestingPro analysis reveals 15 additional key insights about Cencora’s performance and valuation. The achievement of this all-time high reflects positive market sentiment and the effective execution of the company’s strategic initiatives. Investors and analysts will be closely watching how Cencora Inc capitalizes on this momentum in the coming months, with analyst price targets ranging from $274 to $355 per share.

In other recent news, Cencora Inc. reported its third-quarter earnings for 2025, surpassing Wall Street expectations. The company achieved an earnings per share (EPS) of $4, exceeding the forecast of $3.84. Cencora’s revenue also outperformed predictions, reaching $80.7 billion compared to the anticipated $80.31 billion. Despite these positive financial results, the company’s stock experienced a dip due to broader market conditions and potential future challenges. Additionally, Wells Fargo raised its price target for Cencora to $354 from $337, maintaining an Overweight rating. The firm cited strong performance in the U.S. Healthcare sector as a key factor for the adjustment, although international results were moderately weaker. These developments highlight the company’s recent financial and market activities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.